Why Phio Pharmaceuticals Stock Is Nosediving
Why Phio Pharmaceuticals Stock Is Nosediving
The shares available for purchase are part of previously registered stock offerings under Form S-1 and Form S-3.Phio Pharmaceuticals Corp (NASDAQ:PHIO) shares are trading lower by 40% to $0.95 Thursday afternoon after the company announced it will exercise warrants for $2.8 million in gross proceeds.
Phio Pharmicals Corp（纳斯达克股票代码：PHIO）周四下午股价下跌40％，至0.95美元，此前该公司宣布将行使总收益为280万美元的认股权证。
Phio Pharmaceuticals announced that accredited investors agreed to exercise certain warrants to purchase over 2 million shares of the company's stock at a reduced price of $1.33 per share, originally issued between 2018 and 2023 at higher prices.
Phio Pharmicals宣布，合格投资者同意行使某些认股权证，以每股1.33美元的降价购买该公司超过200万股股票，该认股权证最初是在2018年至2023年间以更高的价格发行的。
The exercise of these warrants is expected to bring in around $2.8 million in gross proceeds for the company before factoring in fees and expenses.
在考虑费用和支出之前，这些认股权证的行使预计将为公司带来约280万美元的总收益。
The shares available for purchase are part of previously registered stock offerings under Form S-1 and Form S-3.
可供购买的股票是先前根据表格S-1和S-3注册的股票发行的一部分。
See Also: Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
另见：Phio Pharmicals宣布行使认股权证，总收益为280万美元
According to data from Benzinga Pro, PHIO has a 52-week high of $12.27 and a 52-week low of $0.88.
根据Benzinga Pro的数据，PHIO创下52周高点12.27美元，52周低点0.88美元。
